⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
TYRA News
Tyra Biosciences, Inc. Common Stock
Tyra Biosciences Announces Participation at Upcoming Investor Events
prnewswire.com
TYRA
Tyra Biosciences Reports Third Quarter 2025 Financial Results and Highlights
prnewswire.com
TYRA
Tyra Biosciences Announces First Child Dosed in BEACH301, its Phase 2 Study for Dabogratinib (TYRA-300) in Pediatric Achondroplasia
prnewswire.com
TYRA
TYRA